MCT Bioseparation Aps: Financial statements 2024
CVR: 41269774
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MCT Bioseparation Aps (CVR 41269774) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 244,746 and a net result of DKK 38,425 compared with DKK 55,136 the year before. That is a decrease of 2.3% compared with the year before. The profit margin was 15.7%. Equity in the 2024 report amounted to DKK 54,892. The solvency ratio was 100%.
- Revenue
- DKK 244,746
- Gross Profit
- DKK 236,301
- Profit/Loss
- DKK 38,425
- Equity
- DKK 54,892
- Total Assets
- DKK 54,892
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 245K | 236K | 38K | 55K | - |
| 2023 | 250K | 236K | 55K | 16K | - |
| 2022 | 519K | 484K | -56K | -39K | - |
| 2021 | 0 | -14K | -15K | 304K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MCT Bioseparation Aps has published its annual report for 2023. Revenue came to DKK 250,499, and the net result was DKK 55,136.
About MCT Bioseparation Aps
MCT Bioseparation Aps is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Meyer Chroma Technology ApS. The management consists of Jørgen Vonsild Skjøde. The company's owners include John Bagterp Jørgensen, Jørgen Vonsild Skjøde and Jacob Skjøde. The company has 1 employee (2025). In 2025, the company reported revenue of DKK 138,591 and a net result of DKK -42 compared with DKK 38,425 the year before. Equity in the 2025 report amounted to DKK 49,958.